Nutrition & IV drug
Development of nutritional status improvement products and patient disease treatment products based on JW Life Sciences' liquid product research and production know-how
Developing various types of products containing glucose, amino acids, lipids and trace elements required to improve patient nutrition
Developing liquid therapeutics for various fields.
|Description||Major Products||Container Types|
|Basic I.V. Solutions||
|I.V. Drugs & Specialty Solutions||
Container closure system
Development of liquid packaging and hospital supplies through JW Life Science's development of liquid product packaging materials and research on high functional (oxygen / moisture barrier) materials
Container Closure System means the entire packaging component that contains and protects the formulation.
CCS consists of a primary packaging component that is a part of the package that is in direct contact with the formulation and a secondary packaging component that is a part that is not in direct contact with the formulation.
The HP R&D Center of JW Life Sciences has achieved a global level of CCS through continuous research and expertise based on the know-how accumulated by a team of experts leading domestic IV solution related technologies.
Although bottle containers have been mainly used since the production of IV solution, plastic containers have appeared all over the world due to problems such as bottle weight and risk of damage.
Plastic containers can be classified into PVC and Non-PVC
PVC is an infusion container material that is widely used worldwide because of its low cost and easy molding.
However, DEHP, a plasticizer used to improve flexibility in the manufacturing process during molding, is a kind of environmental hormone, and risks in human body such as reproductive toxicity are emerging.
In addition, chloride of PVC has been found to make dioxin, a carcinogen when incinerated. In Korea and abroad, regulations have been made on PVC using phthalate plasticizers such as DEHP in IV solution containers.
Non-PVC is a general term for materials other than PVC. In the IV solution container, PP, PE or its composites are used, which has the advantages of being an environmentally friendly material, but requires high technical skills in processing. JW started the research of Non-PVC containers in the 1990s and developed its own technology for non-PVC IV solution containers, leading the advancement of domestic IV solution containers. In addition, JW has acquired the US FDA in 2003 and CFDA in China in 2004, and is actively engaged in overseas business such as exporting non-PVC IV solution film to China.
To be used as an infusion container, the following conditions must be satisfied.
|Material||Silicon||PVC||PE or PP||PP or composite|
Good barrier property
Accurate capacity display line
stability Good flexibility
Difficulties in handling
|Limited drug stability
DEHP (Environmental Hormone) Elution
Dioxin (carcinogen) emission
|Poor flexibility||High price
Material : polypropylene multilayer plastic
Form : Mono bag, 2CB, 3CB, etc
Specification : 50mL, 100mL, 250mL, 500mL, 1000mL, 2000mL
Material : Polypropylene
Lightweight and easy to handle as it is not damaged by physical impact.
Specification : 50mL, 100mL
Material : Polypropylene
Specification : 1000mL
Material : HDPE
Specification : 5.5L, 7L, 10L, 12.6L